Administrative Core for Institution # 269291
机构行政核心
基本信息
- 批准号:10475406
- 负责人:
- 金额:$ 25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-05 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccountabilityAcquired Immunodeficiency SyndromeAffectAreaAssessment toolAwardBasic ScienceBiological AssayBiometryCatalogingCatalogsCell LineCellsCellular AssayCentral Nervous System Viral DiseasesCitiesClinicClinicalCollaborationsCollectionCommunicable DiseasesCommunicationCommunitiesCountryDataData AnalysesData CollectionDevelopmentEducational workshopEnsureEvaluationFosteringFundingGenesGoalsGrantHIVHIV-1ImpairmentIndividualInfrastructureInstitutesInstitutionInternationalLaboratory ResearchLeadershipLearningMeasuresMedicineMental disordersMentorshipMicroelectrodesMissionNational Institute of Mental HealthNeurologyNeuronsNeurosciencesOffice of Administrative ManagementOutcomeParticipantPerformancePersonsPhiladelphiaPhysiciansPlayProceduresProcessProductivityReportingResearchResearch PersonnelResearch SupportResourcesRoleScientistSeedsSelf AssessmentSeriesSocietiesSourceSpecimenStrategic PlanningStressTimeUnited States National Institutes of HealthUniversitiesUpdateViralVirusbasecell behaviorcohesioncohortcollegecommunity partnershipgenetic analysisgraduate studentimprovedinduced pluripotent stem cellinterestmicroscopic imagingnervous system disorderneuroAIDSneurobehavioraloperationpatient populationprogramsrecruitresponsestem cellssymposiumsynergismtool
项目摘要
SUMMARY
The main objective of the Central Administrative and Management Core (CAMC) is to serve as the anchor and
to provide administrative oversight for the Comprehensive NeuroHIV Center (CNHC) at Temple University and
Drexel University in Philadelphia. The overall objective is to improve and expand research related to neuroHIV
and neurological diseases associated with viral infection of the CNS including neurobehavioral impairment and
mental disorders. The infrastructure created by the CNHC during the last 10 years offers unique expertise to
local, regional, and national neuroHIV investigators with focus on our strengths of gene editing and delivery,
mammalian progenitor cells and iPSC cultures, assist investigators with genetic analysis of virus-infected cells
before and after editing procedures, and support for a full-range of state-of-the-art microscopic and imaging
analysis. At the same time, the CNHC will coordinate the NeuroHIV Community Partnership and Disparity Core
affecting PWH, the newly developed core that is now included in our program. The CAMC will assist with liaising
with current and potential community partners in fostering synergy among the patient population and the
participant researchers. Tkhe Center offers its unique expertise in functional cellular assays including
microelectrode array assay to study neuronal cell behavior in response to external stress. Furthermore, the
Center will enable investigators to initiate clinical and neurobehavioral examination with a well-established cohort
of people with HIV (PWH) longitudinally examined at Drexel University College of Medicine. The CAMC will
provide the infrastructure for coordinating and overseeing all activities of the CNHC and facilitating synergistic
interaction among the cores and other NIMH-supported Centers. The CAMC will delineate the strategic plan,
identify short- and long-term objectives, execute detailed plans to be implemented, carry out internal and external
reviews and assessment tools based on established criteria to ensure productive and efficient use of resources
to achieve the overall objectives of the CNHC. It will also offer biostatistical support for data analysis and
interpretation obtained from the basic science and clinical cores. In addition, this Core will coordinate with the
Scientific Cores to disseminate information to the participants as well as Core users, recruit Core users, solicitate
pilot applications, catalogue all original data generated by the Cores, facilitate and track all material distributed
by the Cores, including, but not limited to, cell lines, viral stocks, and clinical specimens.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(13)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kamel Khalili其他文献
Kamel Khalili的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kamel Khalili', 18)}}的其他基金
HIV modulation of BAG3 impacting quality control of Tau in neuronal cells
HIV 对 BAG3 的调节影响神经元细胞中 Tau 的质量控制
- 批准号:
10437950 - 财政年份:2018
- 资助金额:
$ 25万 - 项目类别:
HIV modulation of BAG3 impacting quality control of Tau in neuronal cells
HIV 对 BAG3 的调节影响神经元细胞中 Tau 的质量控制
- 批准号:
10170194 - 财政年份:2018
- 资助金额:
$ 25万 - 项目类别:
HIV modulation of BAG3 impacting quality control of Tau in neuronal cells
HIV 对 BAG3 的调节影响神经元细胞中 Tau 的质量控制
- 批准号:
9922215 - 财政年份:2018
- 资助金额:
$ 25万 - 项目类别:
Nanotechnology Based Gene Editing to Eradicate HIV Brain Reservoir in Drug Abusers
基于纳米技术的基因编辑可根除吸毒者体内的艾滋病毒脑库
- 批准号:
9318489 - 财政年份:2016
- 资助金额:
$ 25万 - 项目类别:
Viral Gene Editing and Bioinformatics Core for Institution # 269291
机构病毒基因编辑和生物信息学核心
- 批准号:
10475410 - 财政年份:2011
- 资助金额:
$ 25万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 25万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 25万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 25万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 25万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 25万 - 项目类别:














{{item.name}}会员




